Intuitive Surgical Inc
NASDAQ:ISRG
Net Margin
Intuitive Surgical Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.6B USD |
28%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
228.5B USD |
32%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
147.4B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
144B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
114B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
65.7B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.1B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
42.4B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.8B CNY |
33%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.3B USD |
10%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
34.8B USD |
23%
|
Intuitive Surgical Inc
Glance View
In the rapidly evolving landscape of medical technology, Intuitive Surgical Inc. stands as a pioneer, revolutionizing the way surgeries are performed through its groundbreaking robotic systems. Founded in 1995, the company has set the benchmark for minimally invasive surgery with its flagship product, the da Vinci Surgical System. This sophisticated platform integrates advanced robotics, 3D visualization, and intuitive controls to enable surgeons to perform intricate procedures with precision and control that far surpass conventional methods. By enhancing the dexterity of the human hand and allowing for remarkably steady movements, the system reduces the physical strain on surgeons while improving patient outcomes in terms of reduced recovery time, minimized scarring, and lower risk of infection. Intuitive Surgical’s business model is both innovative and practical, capitalizing on a combination of product sales, ongoing service agreements, and instrument and accessory sales. Initially, hospitals and medical centers invest significantly in acquiring the da Vinci Systems, providing Intuitive with substantial capital inflows. However, the true genius of the company's revenue model lies in its ecosystem approach; ongoing revenue is generated through the sale of disposable instruments and components needed for each surgery. Additionally, the firm offers extensive maintenance and support services, ensuring that healthcare providers maximize their return on investment while maintaining optimal performance of their surgical systems. This balanced model creates a consistent and reliable income stream, enhancing the company's financial stability and enabling it to invest continually in research and development.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Intuitive Surgical Inc's most recent financial statements, the company has Net Margin of 27.8%.
You don't have any saved screeners yet